BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 11908493)

  • 1. Thalidomide in Behçet's disease.
    Shek LP; Lim DL
    Biomed Pharmacother; 2002 Feb; 56(1):31-5. PubMed ID: 11908493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thalidomide responsiveness in an infant with Behçet's syndrome.
    Shek LP; Lee YS; Lee BW; Lehman TJ
    Pediatrics; 1999 Jun; 103(6 Pt 1):1295-7. PubMed ID: 10353947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNF-alpha antagonists and thalidomide for the management of gastrointestinal Behçet's syndrome refractory to the conventional treatment modalities: a case series and review of the literature.
    Hatemi I; Hatemi G; Pamuk ON; Erzin Y; Celik AF
    Clin Exp Rheumatol; 2015; 33(6 Suppl 94):S129-37. PubMed ID: 26486925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Weight gain during treatment with thalidomide: a case report].
    Comte H; Béné J; Auffret M; Gautier S; Salle-Staumont D
    Therapie; 2014; 69(5):457-9. PubMed ID: 25285366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thalidomide: focus on its employment in rheumatologic diseases.
    Ossandon A; Cassarà EA; Priori R; Valesini G
    Clin Exp Rheumatol; 2002; 20(5):709-18. PubMed ID: 12412207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positioning of apremilast in treatment of Behçet's disease.
    Takeno M
    Mod Rheumatol; 2020 Mar; 30(2):219-224. PubMed ID: 31747804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel approaches to Behçet's disease.
    Sakane T; Takeno M
    Expert Opin Investig Drugs; 2000 Sep; 9(9):1993-2005. PubMed ID: 11060788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Behçet's disease with thalidomide.
    Hamza MH
    Clin Rheumatol; 1986 Sep; 5(3):365-71. PubMed ID: 3780143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A patient with neuro-Behçet's disease is successfully treated with etanercept: further evidence for the value of TNFalpha blockade.
    Alty JE; Monaghan TM; Bamford JM
    Clin Neurol Neurosurg; 2007 Apr; 109(3):279-81. PubMed ID: 17174468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Apremilast for Aphthous Ulcers in a Patient With Behçet’s Syndrome.
    Saini A; Ferguson C; Salkey K
    J Drugs Dermatol; 2018 Dec; 17(12):1328-1329. PubMed ID: 30586267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thalidomide in the treatment of aphthosis and Behçet's disease. 4 years' experience].
    Torras H; Lecha M; Mascaró/ JM
    Med Cutan Ibero Lat Am; 1982; 10(2):103-112. PubMed ID: 6759802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent aphthous stomatitis of the Behçet's type: successful treatment with thalidomide.
    Eisenbud L; Horowitz I; Kay B
    Oral Surg Oral Med Oral Pathol; 1987 Sep; 64(3):289-92. PubMed ID: 3477744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Managing the symptoms of Behçet's disease.
    Evereklioglu C
    Expert Opin Pharmacother; 2004 Feb; 5(2):317-28. PubMed ID: 14996628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Adamantiades-Behçet's disease. Clinical review].
    Störk S; Kneitz C; Bröcker EB; Hoyer C; Ertl G; Angermann CE
    Med Klin (Munich); 2008 Mar; 103(3):143-52. PubMed ID: 18344064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behçet's disease. Report of twenty-five patients from the United States with prominent mucocutaneous involvement.
    Mangelsdorf HC; White WL; Jorizzo JL
    J Am Acad Dermatol; 1996 May; 34(5 Pt 1):745-50. PubMed ID: 8632067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behçet's disease and complex aphthosis.
    Ghate JV; Jorizzo JL
    J Am Acad Dermatol; 1999 Jan; 40(1):1-18; quiz 19-20. PubMed ID: 9922007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of intestinal Behçet's syndrome with chimeric tumour necrosis factor alpha antibody.
    Travis SP; Czajkowski M; McGovern DP; Watson RG; Bell AL
    Gut; 2001 Nov; 49(5):725-8. PubMed ID: 11600479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sucessful use of thalidomide in severe gastrointestinal Behçet's disease.
    Lim YK; Keating JP; Steele R
    ANZ J Surg; 2015 Jun; 85(6):496. PubMed ID: 26031928
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical manifestations and anti-TNF alpha therapy of juvenile Behçet's disease in Taiwan.
    Hu YC; Yang YH; Lin YT; Wang LC; Yu HH; Lee JH; Chiang BL
    BMC Pediatr; 2019 Jul; 19(1):232. PubMed ID: 31296171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Eye and Behçet's disease].
    Ksiaa I; Abroug N; Kechida M; Zina S; Jelliti B; Khochtali S; Attia S; Khairallah M
    J Fr Ophtalmol; 2019 Jun; 42(6):626-641. PubMed ID: 31164292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.